$18.8 Million is the total value of ACACIA RESEARCH CORP's 3 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CMTL | New | COMTECH TELECOMMUNICATIONS C | $15,676,091 | – | 1,291,276 | +100.0% | 83.38% | – |
| CIR | New | CIRCOR INTL INC | $3,092,805 | – | 129,082 | +100.0% | 16.45% | – |
| ITI | New | ITERIS INC NEW | $31,100 | – | 10,000 | +100.0% | 0.16% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| COMTECH TELECOMMUNICATIONS C | 4 | Q3 2023 | 83.4% |
| NEWPARK RES INC | 3 | Q3 2023 | 44.3% |
| ZIMVIE INC | 3 | Q3 2023 | 21.6% |
| THERMON GROUP HLDGS INC | 2 | Q3 2023 | 5.7% |
| CIRCOR INTL INC | 1 | Q4 2022 | 16.5% |
| ITERIS INC NEW | 1 | Q4 2022 | 0.2% |
View ACACIA RESEARCH CORP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Spok Holdings, Inc | June 29, 2022 | 966,883 | - |
| Theravance Biopharma, Inc.Sold out | June 11, 2020 | 0 | 0.0% |
| Evofem Biosciences, Inc. | June 09, 2020 | 1,000 | 0.0% |
| Veritone, Inc. | March 10, 2020 | 1,120,432 | 4.4% |
| IMMERSION CORP | December 26, 2019 | 1,533,991 | - |
View ACACIA RESEARCH CORP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| DEF 14A | 2024-04-19 |
| 8-K | 2024-04-17 |
| 4 | 2024-03-25 |
| 4 | 2024-03-25 |
| 4 | 2024-03-18 |
| 10-K | 2024-03-15 |
| 8-K | 2024-03-14 |
| 8-K | 2024-03-14 |
| 4 | 2024-03-11 |
| 4 | 2024-03-11 |
View ACACIA RESEARCH CORP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.